Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

NIR response type biomimetic membrane nano vesicle as well as construction method and application thereof

A technology of nanovesicles and construction methods, which can be applied to pharmaceutical formulations, preparations for in vivo experiments, medical preparations with non-active ingredients, etc., and can solve problems such as T cell exhaustion and the inability to exert cytotoxic T cell immune response effects , to inhibit the growth of

Active Publication Date: 2021-10-29
THE UNIV OF HONG KONG SHENZHEN HOSPITAL +1
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] studies have found that TILs are often confined to the stromal region of the tumor microenvironment rather than around tumor cells, in which tumor-associated fibroblasts (Cancer-associated fibroblasts, CAFs) pass through Activation of PD-L2 and FASL depletes CD8+ T cells and prevents the immune response of cytotoxic T cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • NIR response type biomimetic membrane nano vesicle as well as construction method and application thereof
  • NIR response type biomimetic membrane nano vesicle as well as construction method and application thereof
  • NIR response type biomimetic membrane nano vesicle as well as construction method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0079] 1) Preparation of an IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE)

[0080] The IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE) provided in Example 1 is synthesized by a substitution method, which specifically includes the following steps:

[0081] Weigh 10mg of IR-780 iodide and 40mg of NH 2 -PEG2000-DSPE, accurately weighed, dissolved in dichloromethane solution to obtain a dichloromethane solution containing IR-780 iodide; with triethylamine (TEA) as the acid-binding agent, triethylamine (TEA) and The molar ratio of IR-780 iodide is 2: 1 ratio and weighs triethylamine (TEA), and adds in the described dichloromethane solution that contains IR-780 iodide, room temperature stirring reaction 24h; After the reaction finishes, Add the reaction solution to 10 times the volume of anhydrous ether, overnight at 4°C, then centrifuge at 3000 rpm for 5 minutes to remove by-products, and then dry the precipitate to obtain IR-780 iodide-modified lipids Graft (IR...

Embodiment 2

[0094] 1) Preparation of an IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE)

[0095] The preparation method of the IR-780 iodide-modified lipid graft (IR780-PEG-2000-DSPE) provided in Example 2 is the same as that in Example 1, and no further description is made here.

[0096] 2) About the construction of a thermosensitive lipid drug delivery system

[0097] The thermosensitive lipid drug delivery system provided in Example 2 is constructed through the following steps:

[0098] Taking the inhibitor BMS202 (BMS) as a model drug, weigh the IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE) obtained in the inhibitor BMS202, Example 1, thermosensitive lipid DPPC and cholesterol respectively, and Dissolve the weighed inhibitor BMS202, IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE), thermosensitive lipid DPPC and cholesterol in ethanol, and heat in a water bath at 60°C to obtain the ethanol phase Solution (in this solution, the mass percentage of inhibitor BM...

Embodiment 3

[0105] 1) Preparation of an IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE)

[0106] The preparation method of the IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE) provided in Example 3 is the same as that in Example 1 and will not be described here.

[0107] 2) About the construction of a thermosensitive lipid drug delivery system

[0108] The thermosensitive lipid drug delivery system provided in Example 3 is prepared through the following steps:

[0109] Taking the inhibitor BMS202 (BMS) as a model drug, weigh the IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE) obtained in the inhibitor BMS202, Example 1, thermosensitive lipid DPPC and cholesterol respectively, and Dissolve the weighed inhibitor BMS202, IR-780 iodide-modified lipid graft (IR780-PEG2000-DSPE), thermosensitive lipid DPPC and cholesterol in ethanol, and heat in a water bath at 60°C to obtain the ethanol phase Solution (in this solution, the mass percentage of inhibitor BMS202 is 20%, t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an NIR response type biomimetic membrane nano vesicle and a construction method and application thereof. The construction method comprises the following steps of S1, collecting tumor cells, and obtaining a tumor cell membrane solution through a freeze thawing method, gradient centrifugation and resuspension in sequence; S2, adopting a solvent diffusion method to obtain a thermosensitive lipid drug delivery system; and S3, mixing the tumor cell membrane solution with a thermosensitive lipid drug delivery system, and performing extruding and filtering by using a liposome extruder to obtain the NIR response type biomimetic membrane nano vesicle. The NIR response type biomimetic cell membrane nano vesicle prepared by the method provided by the invention has a tumor efficient homologous targeting function, further blocks a PD-1 / PD-L1 pathway, reverses a tumor immunosuppression state for a long time, synergistically exerts anti-tumor immune response, and inhibits growth of primary tumors and metastases.

Description

technical field [0001] The invention belongs to the technical field of biopharmaceuticals, and in particular relates to a NIR-responsive biomimetic membrane nanovesicle and its construction method and application. Background technique [0002] Tumor immunotherapy is to activate the body's immune system by introducing a functional antigen-specific immune response to achieve long-term immune memory, prevention and killing of tumor cells. However, currently about 85% of tumor patients do not respond well to immunotherapy. Studies have found that the tumor microenvironment can protect tumor cells and perform immune escape through mechanisms such as immunosuppression. [0003] Immune checkpoint blockade (ICB) therapy, which reverses the tumor immunosuppressive tumor microenvironment (TME), has become the main way of immunotherapy. Among them, ICB therapy targeting the PD-1 / PD-L1 pathway has shown significant clinical efficacy in various types of cancers such as melanoma, non-sma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/127A61K41/00A61K45/00A61K47/46A61K49/00A61P35/00A61P35/04
CPCA61K41/0052A61K41/0028A61K9/1271A61K9/1277A61K47/46A61K45/00A61P35/00A61P35/04A61K49/0021A61K49/0084
Inventor 谭亚南关新元李咏梅李珊珊罗敏
Owner THE UNIV OF HONG KONG SHENZHEN HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com